These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19708663)

  • 41. Evaluation of O-antigen inactivation on Pla activity and virulence of Yersinia pseudotuberculosis harbouring the pPla plasmid.
    Pouillot F; Derbise A; Kukkonen M; Foulon J; Korhonen TK; Carniel E
    Microbiology (Reading); 2005 Nov; 151(Pt 11):3759-3768. PubMed ID: 16272397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of chromosomal regions conserved in Yersinia pseudotuberculosis and lost by Yersinia pestis.
    Pouillot F; Fayolle C; Carniel E
    Infect Immun; 2008 Oct; 76(10):4592-9. PubMed ID: 18678673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased virulence of Yersinia pseudotuberculosis by two independent mutations.
    Rosqvist R; Skurnik M; Wolf-Watz H
    Nature; 1988 Aug; 334(6182):522-4. PubMed ID: 3043229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of modeled microgravity on growth kinetics, antibiotic susceptibility, cold growth, and the virulence potential of a Yersinia pestis ymoA-deficient mutant and its isogenic parental strain.
    Lawal A; Kirtley ML; van Lier CJ; Erova TE; Kozlova EV; Sha J; Chopra AK; Rosenzweig JA
    Astrobiology; 2013 Sep; 13(9):821-32. PubMed ID: 23988036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense.
    Zheng Y; Lilo S; Mena P; Bliska JB
    PLoS One; 2012; 7(4):e36019. PubMed ID: 22563435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Yersinia pseudotuberculosis and Yersinia pestis toxin complex is active against cultured mammalian cells.
    Hares MC; Hinchliffe SJ; Strong PCR; Eleftherianos I; Dowling AJ; Ffrench-Constant RH; Waterfield N
    Microbiology (Reading); 2008 Nov; 154(Pt 11):3503-3517. PubMed ID: 18957603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential impact of lipopolysaccharide defects caused by loss of RfaH in Yersinia pseudotuberculosis and Yersinia pestis.
    Hoffman JM; Sullivan S; Wu E; Wilson E; Erickson DL
    Sci Rep; 2017 Sep; 7(1):10915. PubMed ID: 28883503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentaplex real-time PCR for differential detection of Yersinia pestis and Y. pseudotuberculosis and application for testing fleas collected during plague epizootics.
    Bai Y; Motin V; Enscore RE; Osikowicz L; Rosales Rizzo M; Hojgaard A; Kosoy M; Eisen RJ
    Microbiologyopen; 2020 Oct; 9(10):e1105. PubMed ID: 32783386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temperature sensing in Yersinia pestis: translation of the LcrF activator protein is thermally regulated.
    Hoe NP; Goguen JD
    J Bacteriol; 1993 Dec; 175(24):7901-9. PubMed ID: 7504666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis.
    Hinchliffe SJ; Isherwood KE; Stabler RA; Prentice MB; Rakin A; Nichols RA; Oyston PC; Hinds J; Titball RW; Wren BW
    Genome Res; 2003 Sep; 13(9):2018-29. PubMed ID: 12952873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability.
    Grier MC; Garrity-Ryan LK; Bartlett VJ; Klausner KA; Donovan PJ; Dudley C; Alekshun MN; Tanaka SK; Draper MP; Levy SB; Kim OK
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3380-3. PubMed ID: 20434913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current trends in plague research: from genomics to virulence.
    Huang XZ; Nikolich MP; Lindler LE
    Clin Med Res; 2006 Sep; 4(3):189-99. PubMed ID: 16988099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Yersinia pestis and approaches to targeting its outer protein H protein-tyrosine phosphatase (YopH).
    Bahta M; Burke TR
    Curr Med Chem; 2012; 19(33):5726-34. PubMed ID: 22934808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
    Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
    Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague.
    Taylor VL; Titball RW; Oyston PCF
    Microbiology (Reading); 2005 Jun; 151(Pt 6):1919-1926. PubMed ID: 15941999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b.
    Skurnik M; Peippo A; Ervelä E
    Mol Microbiol; 2000 Jul; 37(2):316-30. PubMed ID: 10931327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LcrQ Coordinates with the YopD-LcrH Complex To Repress
    Fei K; Yan H; Zeng X; Huang S; Tang W; Francis MS; Chen S; Hu Y
    mBio; 2021 Jun; 12(3):e0145721. PubMed ID: 34154409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.
    Brodsky IE; Medzhitov R
    PLoS Pathog; 2008 May; 4(5):e1000067. PubMed ID: 18483548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.